AGIO
Price
$32.50
Change
-$0.26 (-0.79%)
Updated
Apr 30, 6:59 PM EST
One day until earnings call
MLYS
Price
$12.61
Change
+$0.36 (+2.94%)
Updated
May 1, 9:24 AM EST
12 days until earnings call
Ad is loading...

AGIO vs MLYS ᐉ Comparison: Which is Better to Invest?

Header iconAGIO vs MLYS Comparison
Open Charts AGIO vs MLYSBanner chart's image
Agios Pharmaceuticals
Price$32.50
Change-$0.26 (-0.79%)
Volume$284.48K
CapitalizationN/A
Mineralys Therapeutics
Price$12.61
Change+$0.36 (+2.94%)
Volume$200
CapitalizationN/A
View a ticker or compare two or three
AGIO vs MLYS Comparison Chart

Loading...

AGIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
MLYSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AGIO vs. MLYS commentary
May 01, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a Hold and MLYS is a Hold.

COMPARISON
Comparison
May 01, 2024
Stock price -- (AGIO: $32.50 vs. MLYS: $12.25)
Brand notoriety: AGIO and MLYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 97% vs. MLYS: 139%
Market capitalization -- AGIO: $1.85B vs. MLYS: $607.98M
AGIO [@Biotechnology] is valued at $1.85B. MLYS’s [@Biotechnology] market capitalization is $607.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $566.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 0 FA rating(s) are green whileMLYS’s FA Score has 0 green FA rating(s).

  • AGIO’s FA Score: 0 green, 5 red.
  • MLYS’s FA Score: 0 green, 5 red.
According to our system of comparison, both AGIO and MLYS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 5 TA indicator(s) are bullish while MLYS’s TA Score has 5 bullish TA indicator(s).

  • AGIO’s TA Score: 5 bullish, 5 bearish.
  • MLYS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AGIO is a better buy in the short-term than MLYS.

Price Growth

AGIO (@Biotechnology) experienced а +2.17% price change this week, while MLYS (@Biotechnology) price change was +7.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.16%. For the same industry, the average monthly price growth was -5.25%, and the average quarterly price growth was +1237.40%.

Reported Earning Dates

AGIO is expected to report earnings on Aug 01, 2024.

MLYS is expected to report earnings on May 13, 2024.

Industries' Descriptions

@Biotechnology (+2.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AGIO with price predictions.
OPEN
A.I.dvisor published
a Summary for MLYS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
AGIO($1.85B) has a higher market cap than MLYS($608M). AGIO YTD gains are higher at: 45.936 vs. MLYS (42.442).
AGIOMLYSAGIO / MLYS
Capitalization1.85B608M304%
EBITDAN/AN/A-
Gain YTD45.93642.442108%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
AGIO: Fundamental Ratings
AGIO
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGIOMLYS
RSI
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
45%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
73%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 16 days ago
79%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
AGIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
MLYSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRKUX13.17-0.12
-0.90%
MFS Blended Research Em Mkts Eq R4
DDIAX14.25-0.15
-1.04%
Delaware Wealth Builder A
JUEMX22.76-0.30
-1.30%
JPMorgan US Equity R6
TGDFX22.33-0.39
-1.72%
TCW Relative Value Dividend Apprec I
AAAGX16.06-0.30
-1.83%
Thrivent Large Cap Growth A

AGIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGIO has been loosely correlated with NTLA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if AGIO jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGIO
1D Price
Change %
AGIO100%
-0.79%
NTLA - AGIO
51%
Loosely correlated
-2.64%
RARE - AGIO
50%
Loosely correlated
-3.36%
BEAM - AGIO
49%
Loosely correlated
-3.76%
DNLI - AGIO
47%
Loosely correlated
-1.03%
ALLO - AGIO
46%
Loosely correlated
-2.82%
More

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with FOLD. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then FOLD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
-0.97%
FOLD - MLYS
52%
Loosely correlated
-2.54%
NTLA - MLYS
48%
Loosely correlated
-2.64%
AGIO - MLYS
45%
Loosely correlated
-0.79%
PCVX - MLYS
45%
Loosely correlated
-0.79%
PRME - MLYS
43%
Loosely correlated
+1.23%
More